Skip to content
← Full study record

NCT01142232 · MORE INFO

Limitations, agreements, and source contact

Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma · Source last updated 2019-10-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
asuvanna@iu.edu
organization
IndianaU
phone
(317) 278-9306
title
Dr. Attaya Suvannasankha
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
asuvanna@iu.edu
organization
IndianaU
phone
(317) 278-9306
title
Dr. Attaya Suvannasankha

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice